Pharmaceutical Technology1 天
ENA-001 by Enalare Therapeutics for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
ENA-001 is under clinical development by Enalare Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19).